Yi, Z. 2024. Inhibition of integrin receptor by increasing concentrations and treatment durations with Cilengitide increases the sensitivity of killing in vivo of U87 glioma cancer cell xenograft mouse. MedScien. 2, 1 (Feb. 2024), 382. DOI:https://doi.org/10.61173/hsv29020.